Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
2
×
boston top stories
clinical trials
life sciences
national blog main
new york blog main
alder biopharmaceuticals
amgen
boston
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
cancer
chronic migraine
codiak biosciences
cutaneous t-cell lymphoma
david rind
detroit blog main
detroit top stories
eli lilly
episodic migraine
eptinezumab
erenumab
exosome
fda
food and drug administration
fremanezumab
galcanezumab
indiana blog main
indiana top stories
institute for clinical and economic review
jazz pharmaceuticals
migraine research foundation
migraines
national
national top stories
new york top stories
novartis
raleigh-durham blog main
What
class
2
×
medicines
2
×
new
2
×
amgen
approval
based
begin
biosciences
bio’s
brings
bubbles
candidates
cells
clinical
codiak
developed
drug
exosome
exosomes
fda
formed
fund
gets
head
ipo
migraine
million
nod
pain
preventive
starts
tests
tiny
trials
won
Language
unset
Current search:
class
×
new
×
medicines
×
" boston blog main "
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines